Advances in conversion therapy of unresectable hepatocellular carcinoma
Article in Chinese Journal of Hepatobiliary Surgery (May 2024)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Can adjuvant immune checkpoint inhibitors improve the long-term outcomes of hepatocellular carcinoma with high-risk recurrent factors after liver resection? A meta-analysis and systematic review
Article in Frontiers in Oncology (May 2024)
Postoperative lenvatinib + PD-1 blockade reduces early tumor recurrence in hepatocellular carcinoma with microvascular invasion (Barcelona Clinic Liver Cancer stage 0 or A): a propensity score matching analysis
Article in Journal of Gastrointestinal Surgery (May 2024)